EpiPen maker ties bonuses to profit targets

September 1, 2016 7:44 PM

18 0

Drug maker Mylan (MYL), under fire for sharply raising prices of a life-saving allergy treatment, two years ago urged executives to hit ambitious five-year sales and profit targets with a special incentive plan.

If achieved, the special one-time award, offered to more than 100 "key employees," would mean tens of millions of dollars in bonuses for the executives of the Netherlands-based company.

Also read: Kraft Heinz’s Interest in Unilever Comes Right Out of 3G Capital’s Playbook

Read more

To category page

Loading...